Business Down During Weanling Portion of New Zealand Mixed Sale
Updated: Monday, May 13, 2002 8:47 AM
Posted: Monday, May 13, 2002 8:47 AM
The weanling portion of New Zealand Bloodstock's national mixed sale ended on Monday with downturns from the previous year. The 226 weanlings sold grossed $2,033,250 (approximately $923,096 in U.S. funds) and averaged $7,644 ($3,470). In 2001, the gross and average established sale records for weanlings of $2,149,500 and $9,596, respectively.
The top price of $90,000 ($40,860) was brought by a Carnegie filly produced from Australian group III winner Solop Performance. The filly is a half-sister to Australian group II winner Solo Show and Australian stakes winner Clout. New Zealand Bloodstock purchased the filly on the behalf of an Australian client.
The clearance rate reached a very healthy level of 81%, the same selling rate as last year.
Following the weanling portion, the sale continued with yearlings, 2-year-olds, untried stock, racehorses, and the first of the broodmares being offered.
The top-priced yearling price an $18,000 ($8,172) gelding by Kashani out of Blue Waltz. He was purchased by New Zealand Bloodstock as agent for a Malaysian client.
Top price among the 2-year-olds was the $13,000 ($5,902), given by Neville Atkins of Auckland a gelding by Groom Dancer--Lady Paree gelding.
Among untried stock, a King's Theatre --Track Appeal filly fetched the top price of $7,000 ($3,178) from Greg Marcus of Australia.
The top-priced racehorse was Centennial, a stakes-winning daughter of Centaine who was purchased by Kieran Moore Bloodstock for $16,000 ($7,264).
The first 60 of the 325 broodmares catalogued were offered. The top price was the $48,000 ($21,792) given by Endeavour Capital for Amber Ace, who was stakes-placed as a 2-year-old. .Her first foal is a colt by Cape Cross and she was sold in foal to O' Reilly.
FREE! E-Newsletters from The Blood-Horse!...
Follow the top stories of major racing events, racing previews and results with FREE e-newsletters from bloodhorse.com. As news develops, we'll deliver updates to your inbox. Follow important events moment by moment, step by step!